NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds investors of the common stock of Axsome Therapeutics, Inc. (“Axsome”) AXSM of the…
Tag: Therapeutics
ROSEN, A LEADING LAW FIRM, Encourages Outlook Therapeutics,
NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities…